相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of PD-L1 expression in the tumor microenvironment
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer
Yilmaz Ba et al.
TRANSLATIONAL ONCOLOGY (2021)
PD-1 and PD-L1 expression on TILs in peritoneal metastases compared to ovarian tumor tissues and its associations with clinical outcome
Christine Bekos et al.
SCIENTIFIC REPORTS (2021)
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Panagiotis A. Konstantinopoulos et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Persistent DNA damage triggers activation of the integrated stress response to promote cell survival under nutrient restriction
Elena Clementi et al.
BMC BIOLOGY (2020)
Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer
Wenjuan Tian et al.
CANCER MEDICINE (2020)
Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
Fulvio Borella et al.
DIAGNOSTICS (2020)
The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers
Omid Kooshkaki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
DNA Repair and Ovarian Carcinogenesis: Impact on Risk, Prognosis and Therapy Outcome
Kristyna Tomasova et al.
CANCERS (2020)
PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
William P. Tew et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Mitochondrial superoxide contributes to oxidative stress exacerbated by DNA damage response in RAD51-depleted ovarian cancer cells
Limei Xu et al.
REDOX BIOLOGY (2020)
Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials
Bin Zhao et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis
Vanda Teglasi et al.
CLINICAL LUNG CANCER (2019)
Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches
Alberto Farolfi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
DNA damage measurements within tissue samples with Repair Assisted Damage Detection (RADD)
Kevin J. Lee et al.
CURRENT RESEARCH IN BIOTECHNOLOGY (2019)
Simultaneous detection of multiple DNA damage types by multi-colour fluorescent labelling
Dmitry Torchinsky et al.
CHEMICAL COMMUNICATIONS (2019)
Broad spectrum detection of DNA damage by Repair Assisted Damage Detection (RADD)
Nathaniel W. Holton et al.
DNA REPAIR (2018)
The interplay of reactive oxygen species and the epidermal growth factor receptor in tumor progression and drug resistance
Meng-Shih Weng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms
Christina Koppel et al.
MODERN PATHOLOGY (2018)
DNA damage repair in ovarian cancer: unlocking the heterogeneity
Mary Ellen Gee et al.
JOURNAL OF OVARIAN RESEARCH (2018)
Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts
Arnaud J. Legrand et al.
Oncotarget (2018)
DNA repair defects and implications for immunotherapy
Katherine M. Bever et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
Hiro Sato et al.
NATURE COMMUNICATIONS (2017)
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw et al.
CANCER DISCOVERY (2017)
PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
Hashem O. Alsaab et al.
FRONTIERS IN PHARMACOLOGY (2017)
PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
John R. Webb et al.
GYNECOLOGIC ONCOLOGY (2016)
Avelumab (MSB0010718C; anti-PD-L1) in patients with recurrent/refractory ovarian cancer from the JAVELIN Solid Tumor phase Ib trial: Safety and clinical activity.
Mary L. Disis et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management
Assunta Sgambato et al.
CURRENT DRUG SAFETY (2016)
DNA Damage in Cancer Therapeutics: A Boon or a Curse?
Anchit Khanna
CANCER RESEARCH (2015)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER DISCOVERY (2015)
Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study.
Andrea Varga et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Lighting Up Individual DNA Damage Sites by In Vitro Repair Synthesis
Shahar Zirkin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Comparison of advanced stage mucinous epithelial ovarian cancer and serous epithelial ovarian cancer with regard to chemosensitivity and survival outcome: a matched case-control study
Emine Karabuk et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2013)
Mammalian Base Excision Repair: the Forgotten Archangel
Grigory L. Dianov et al.
NUCLEIC ACIDS RESEARCH (2013)
Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER RESEARCH (2011)
Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
Masayuki Nitta et al.
PLOS ONE (2010)
The DNA-damage response in human biology and disease
Stephen P. Jackson et al.
NATURE (2009)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
Mucinous ovarian cancer
M. L. Harrison et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
DNA damage response as an anti-cancer barrier - Damage threshold and the concept of 'conditional haploinsufficiency'
Jiri Bartek et al.
CELL CYCLE (2007)
Temperature dependence and thermodynamics of Klenow polymerase binding to primed-template DNA
K Datta et al.
BIOPHYSICAL JOURNAL (2006)
Technical aspects of immunohistochemistry
JA Ramos-Vara
VETERINARY PATHOLOGY (2005)
Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis -: A mutational analysis with immunohistochemical correlation
G Singer et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
分享论文
